Lucene search

[email protected]CVE-2019-7264

HistoryJul 02, 2019 - 5:15 p.m.

CVE-2019-7264

2019-07-0217:15:12

CWE-787

[email protected]

web.nvd.nist.gov

cve-2019-7264

linear emerge e3-series

stack-based buffer overflow

arm platform

nvd

7.5 High

CVSS2

Attack Vector

NETWORK

Attack Complexity

LOW

Authentication

NONE

Confidentiality Impact

PARTIAL

Integrity Impact

PARTIAL

Availability Impact

PARTIAL

AV:N/AC:L/Au:N/C:P/I:P/A:P

9.8 High

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

9.4 High

AI Score

Confidence

High

0.002 Low

EPSS

Percentile

61.9%

JSON

Linear eMerge E3-Series devices allow a Stack-based Buffer Overflow on the ARM platform.

Affected configurations

NVD

Node

nortekcontrollinear_emerge_essential_firmwareRange≤1.00-06

AND

nortekcontrollinear_emerge_essentialMatch-

Node

nortekcontrollinear_emerge_elite_firmwareRange≤1.00-06

AND

nortekcontrollinear_emerge_eliteMatch-

CPENameOperatorVersion
nortekcontrol:linear_emerge_essential_firmwarenortekcontrol linear emerge essential firmwarele1.00-06

CPE	Name	Operator	Version
nortekcontrol:linear_emerge_essential_firmware	nortekcontrol linear emerge essential firmware	le	1.00-06

References

applied-risk.com/labs/advisories

www.applied-risk.com/resources/ar-2019-005

7.5 High

CVSS2

Attack Vector

NETWORK

Attack Complexity

LOW

Authentication

NONE

Confidentiality Impact

PARTIAL

Integrity Impact

PARTIAL

Availability Impact

PARTIAL

AV:N/AC:L/Au:N/C:P/I:P/A:P

9.8 High

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

9.4 High

AI Score

Confidence

High

0.002 Low

EPSS

Percentile

61.9%

JSON

Related for CVE-2019-7264

prion1 cvelist1 nvd1 ics1